Skip to main content

GH

Stock

GH

Stock
Health Care
Diagnostics & Research

Performance overview

GH Price
Price Chart

Forward-looking statistics

Beta
1.77
Risk
71.36%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees2K
Market cap$3.5B

Fundamentals

Enterprise value$7.1B
Revenue$774.0M
Revenue per employee
Profit margin-53.82%
Debt to equity-5.21

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.39
Dividend per share
Revenue per share$6.28
Avg trading volume (30 day)$107M
Avg trading volume (10 day)$100M
Put-call ratio

Macro factor sensitivity

Growth-2.7
Credit+7.5
Liquidity-0.6
Inflation-6.5
Commodities-1.4
Interest Rates-2.3

Valuation

Dividend yield0.00%
PEG Ratio-18.63
Price to sales8.08
P/E Ratio-18.63
Enterprise Value to Revenue9.12
Price to book-24.94

Upcoming events

Next earnings dayAugust 6, 2025
Next dividend day
Ex. dividend day

News

Super Group (SGHC) Limited (SGHC) Stock Declines While Market Improves: Some Information for Investors

Super Group (SGHC) Limited (SGHC) closed at $11.79 in the latest trading session, marking a -1.67% move from the prior day.

Zacks Investment Research (July 10, 2025)
Graham (GHM) Surges 7.4%: Is This an Indication of Further Gains?

Graham (GHM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research (June 24, 2025)
TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?

GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.

Zacks Investment Research (June 23, 2025)
Super Group (SGHC) Limited (SGHC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Super Group (SGHC) Limited (SGHC) closed the most recent trading day at $9.68, moving 1.02% from the previous trading session.

Zacks Investment Research (June 20, 2025)
New Strong Buy Stocks for June 16th

FLXS, ROK, SSP, VIRT and GHI have been added to the Zacks Rank #1 (Strong Buy) List on June 16, 2025.

Zacks Investment Research (June 16, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free